Innospec (IOSP) Projected to Announce Earnings on Tuesday

Key Points

• Innospec is expected to report Q3 2026 earnings after the market closes on Tuesday, November 3. Analysts forecast $1.26 in EPS and $479.17 million in revenue, with the earnings call scheduled for November 4.
• In the prior quarter, Innospec earned $1.27 per share, exceeding estimates by $0.22, while revenue rose 11.8% year over year to $491.4 million.
• Shares recently opened at $99.18, near their 52-week high of $100.62. Despite a $110 price target from Seaport Research Partners, analysts have a consensus “Hold” rating.

Innospec (NASDAQ:IOSP - Get Free Report) is expected to announce its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect Innospec to post earnings of $1.26 per share and revenue of $479.17 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 9:00 AM ET.

Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.22. The firm had revenue of $491.40 million during the quarter, compared to analyst estimates of $457.25 million. Innospec had a net margin of 6.60% and a return on equity of 9.22%. The business's revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.26 EPS. On average, analysts expect Innospec to post $5.01 EPS for the current fiscal year and $6.25 EPS for the next fiscal year.

Innospec Stock Performance

Shares of NASDAQ:IOSP opened at $99.18 on Tuesday. The company has a market cap of $2.44 billion, a P/E ratio of 20.24, a P/E/G ratio of 2.63 and a beta of 0.90. The stock's 50-day moving average is $95.48 and its 200-day moving average is $84.00. Innospec has a 52-week low of $65.51 and a 52-week high of $100.62.

Analyst Upgrades and Downgrades

IOSP has been the subject of several research analyst reports. Seaport Research Partners reissued a "buy" rating and set a $110.00 price objective on shares of Innospec in a research report on Thursday, August 6th. Weiss Ratings raised Innospec from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, October 8th. Finally, Wall Street Zen downgraded Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 26th. Two research analysts have rated the stock with a Hold rating. According to data from MarketBeat, Innospec presently has a consensus rating of "Hold".

About Innospec

Innospec Inc NASDAQ: IOSP is a global specialty chemicals company that develops, manufactures and markets products used in the fuel, oilfield, personal care and industrial markets. The company serves customers through a portfolio of chemical additives, formulations and technical services designed to improve product performance, efficiency and reliability.

Innospec operates through businesses focused on fuel specialties, performance chemicals and oilfield services. Its fuel-related products include fuel additives for gasoline, diesel, marine and other applications, including detergents, lubricity improvers, cetane improvers and other performance-enhancing formulations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.